Cleared Traditional

K121447 - ISCHEMA VIEW RAPID

K121447 is an FDA 510(k) clearance for ISCHEMA VIEW RAPID, manufactured by Ischemaview, Inc.. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 507-day FDA review.

K121447 · Ischemaview, Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2013
Decision
507d
Days
Class 2
Risk

K121447 is an FDA 510(k) clearance for the ISCHEMA VIEW RAPID. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Ischemaview, Inc. (Irvine, US). The FDA issued a Cleared decision on October 4, 2013 after a review of 507 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate-to-high equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Ischemaview, Inc. devices

FDA 510(k) Submission Details - K121447

510(k) Number K121447 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 15, 2012
Decision Date October 04, 2013
Days to Decision 507 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
400d slower than avg
Panel avg: 107d · This submission: 507d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1235
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K121447.
MULTIVIEW
K132316 · Hologic, Inc. · Oct 2013
MAMMOGRAPHY VIEWER SMV658
K132188 · Fujifilm Medical System U.S.A., Inc. · Oct 2013
DYONICS PLAN HIP IMPINGEMENT PLANNING SYSTEM
K132636 · Smith & Nephew, Inc. · Oct 2013
CENTRICITY UNIVERSAL VIEWER ZERO FOOTPRINT CLIENT
K131977 · Ge Healthcare · Sep 2013
QXLINK
K132302 · Vieworks Co., Ltd. · Sep 2013
JUSHA-C31 MEDICAL DISPLAY
K131389 · Nanjing Jusha Display Technology Co., Ltd. · Sep 2013